“Biohazard Levels In Laboratory Practice And Pharmaceutical Supply Chains: Implications For Healthcare Security And Medical Laboratory Operations”, Rev Diabet Stud, pp. 820–830, Jun. 2024, doi: 10.70082/ax0a7836.